计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| M126999-200mg |
200mg |
现货 ![]() |
| |
| M126999-1g |
1g |
现货 ![]() |
| |
| M126999-5g |
5g |
现货 ![]() |
| |
| M126999-25g |
25g |
现货 ![]() |
|
| 别名 | 米非司酮 | 11β-[4-(N,N-二甲胺基)]苯基-17β-羟基-17α-(1-丙炔基)-雌甾-4,9-二烯-3-酮 | (1Lβ,17β)-11-[4-(二甲氨基)苯基]-17-羟基-17-(1-丙炔基)雌甾-4,9-二烯-3-酮 | 美服培酮 |
|---|---|
| 英文别名 | RU486 | RU 38486 | 11β-[4-(Dimethylamino)phenyl]-17β-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Mifepristone |
| 生化机理 | 米非司酮是一种孕酮(PR)和糖皮质激素受体(GR)拮抗剂,已证明能够抑制 NFκB 的活化,NFκB 是一种核转录因子,会影响各种粘附分子和多种炎症基因的表达。它还是孕酮受体的抑制剂。研究发现,米非司酮可降低 CA1 神经区域和齿状回的基础 bcl-2 信使 RNA 水平。实验表明,米非司酮可能通过调节 FAS 和 FAS-L 细胞凋亡基因的表达,对胚胎植入产生抑制作用。此外,米非司酮还能通过抑制血管内皮生长因子(VEGF)的产生而显示出抗血管生成的特性。米非司酮还可防止细胞内过氧化氢、谷氨酸、β-淀粉样蛋白或神经毒素诱导的过氧化物积聚和细胞死亡,这些都与某些神经退行性疾病相关。它是 PR 的无声拮抗剂,亲和力高于黄体酮。 |
| 储存温度 | 2-8°C储存 |
| 运输条件 | 冰袋运输 |
| 作用类型 | 激动剂 |
| 作用机制 | 孕酮受体拮抗剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
Mifepristone是一种异常活跃的孕激素受体和糖皮质激素受体拮抗剂,IC50分别为0.2nM和2.6 nM。A progesterone and glucocorticoid antagonist, suppresses VEGF production. Mifepristone is a remarkably active antagonist of progesterone receptor and glucocorticoid receptor with IC50 of 0.2 nM and 2.6 nM, respectively. |
| 纯度 | ≥98% |
| ALogP | 3.8 |
|---|
| PubChem SID | 504753683 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | (8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one |
| INCHI | 1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1 |
| InChi Key | VKHAHZOOUSRJNA-GCNJZUOMSA-N |
| Smiles | CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O |
| Isomeric SMILES | CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O |
| 分子量 | 429.59 |
| Reaxy-Rn | 24984138 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=24984138&ln= |
| 溶解性 | Soluble in water (partly), DMF (~30 mg/ml), ethanol (50 mg/ml), methanol, and DMSO (86 mg/ml at 25 °C).(Soluble): chloroform |
|---|---|
| 敏感性 | 对热敏感 |
| 比旋光度 | 141° (C=0.5,CHCl3) |
| 熔点 | 195 °C |
| 分子量 | 429.600 g/mol |
| XLogP3 | 3.800 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 3 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 429.267 Da |
| 单同位素质量Monoisotopic Mass | 429.267 Da |
| 拓扑极表面积Topological Polar Surface Area | 40.500 Ų |
| 重原子数Heavy Atom Count | 32 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 921.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 5 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS08 |
|---|---|
| 信号词 | 危险 |
| 危险声明 |
H302: 吞食有害 H312: 皮肤接触有害 H332: 吸入有害 H360: 可能损害生育力或未出生的孩子 H362: 可能对母乳喂养的孩子造成伤害 |
| 预防措施声明 |
P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P263: 避免在怀孕期间/哺乳期间接触。 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P271: 仅在室外或通风良好的地方使用。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P321: 特殊处理(请参阅此标签上的...)。 P330: 漱口 P302+P352: 如皮肤沾染:用水充分清洗。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P203: 使用前,获取、阅读并遵守所有安全说明。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P318: 如果暴露或担心,请就医。 P317: 寻求紧急医疗救助。 |
| WGK Germany | 3 |
| RTECS | KG2955000 |
| Merck Index | 6186 |
| 个人防护装备 | Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 | |
| 分析证书 | M126999 |
¥239.90
| 1. Zhang B et al.. (2020) Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling.. J Neuroinflammation, 17 (318). [PMID:33100225] |
| 2. Shannon S et al.. (2015) Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells.. PLoS One, 10 (8): (e0135951). [PMID:26284619] |
| 3. Nair M et al.. (2018) Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo.. Int J Mol Sci, 19 (2): [PMID:29443896] |
| 4. Xiao R et al.. (2016) Environmental and Genetic Activation of Hypothalamic BDNF Modulates T-cell Immunity to Exert an Anticancer Phenotype.. Cancer Immunol Res, 4 (6): (488-497). [PMID:27045020] |
| 5. Wang C et al.. (2017) Experimental research on the relationship between the stiffness and the expressions of fibronectin proteins and adaptor proteins of rat trabecular meshwork cells.. BMC Ophthalmol, 17 (268). [PMID:29284449] |
| 6. Karami Kheirabad M et al.. (2015) Expression of Melanocortin-4 Receptor mRNA in Male Rat Hypothalamus During Chronic Stress.. Int J Mol Cell Med, 4 (3): (182-7). [PMID:26629487] |
| 7. Qi-qiang Zhang, Xue-mei Di, Xiang Cao, Yonghong Nie, Wen Shuai, Jun Li, Hai Zhang. (2023) Analysis of pharmacodynamic components, targets and synergistic action mechanism of Fuyuan Shenghua granule for the treatment of medical-induced incomplete abortion based on network pharmacology. JOURNAL OF ETHNOPHARMACOLOGY, (117118). [PMID:37659757] [10.1016/j.jep.2023.117118] |
| 8. Sheng Hu, Pei Shen, Bin Chen, Shao-Wen Tian, Yong You. (2022) Apelin-13 reduces lipopolysaccharide-induced neuroinflammation and cognitive impairment via promoting glucocorticoid receptor expression and nuclear translocation. NEUROSCIENCE LETTERS, 788 (136850). [PMID:36038029] [10.1016/j.neulet.2022.136850] |
| 9. Mengru Bai, Mingyang Chen, Qingquan Zeng, Shuanghui Lu, Ping Li, Zhiyuan Ma, Nengming Lin, Caihong Zheng, Hui Zhou, Su Zeng, Dongli Sun, Huidi Jiang. (2022) Up-regulation of hepatic CD36 by increased corticosterone/cortisol levels via GR leads to lipid accumulation in liver and hypertriglyceridaemia during pregnancy. BRITISH JOURNAL OF PHARMACOLOGY, 179 (17): (4440-4456). [PMID:35491243] [10.1111/bph.15863] |
| 10. Yao Xin-peng, Jiao Ting-ying, Jiang Yi-ming, Fan Shi-cheng, Zhao Ying-yuan, Yang Xiao, Gao Yue, Li Fei, Zhou Yan-ying, Chen Pan-pan, Huang Min, Bi Hui-chang. (2021) PXR mediates mifepristone-induced hepatomegaly in mice. ACTA PHARMACOLOGICA SINICA, 43 (1): (146-156). [PMID:33782543] [10.1038/s41401-021-00633-4] |
| 11. Chang Shu, Teng-Fei Li, Duo Li, Zhong-Qiu Li, Xing-Hua Xia. (2021) Barcode signal amplifying strategy for sensitive and accurate protein detection on LC-MS/MS. ANALYST, 146 (5): (1725-1733). [PMID:33459316] [10.1039/D0AN01948H] |
| 12. Meng Zhang, Yiqing Ye, Zhengyun Chen, Xiaodong Wu, Yue Chen, Pengfei Zhao, Mengdan Zhao, Caihong Zheng. (2024) Targeting Delivery of Mifepristone to Endometrial Dysfunctional Macrophages for Endometriosis Therapy. Acta Biomaterialia, [PMID:39341437] [10.1016/j.actbio.2024.09.037] |
| 13. Lihong Sheng, Jianpeng Gao, Qingyuan Wei, Ye Gong, Zhi-Xiang Xu. (2025) The glial UDP-glycosyltransferase Ugt35b regulates longevity by maintaining lipid homeostasis in Drosophila. Cell Reports, 44 [PMID:39723892] [10.1016/j.celrep.2024.115099] |
| 14. Caiqun Huang. (2024) Toll-like receptor 4 (TLR4) deficiency impedes Toxoplasma gondii excreted-secreted antigens (ESA)-induced abortion. PLACENTA, 154 (1). [PMID:38824786] [10.1016/j.placenta.2024.05.137] |